The translational implications of the science behind the overactive bladder and the role of OnabotulinumtoxinA
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The translational implications of the science behind the overactive bladder and the role of OnabotulinumtoxinA
Authors
Keywords
-
Journal
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-10-26
DOI
10.1016/j.surge.2022.09.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation
- (2018) Steven Siegel et al. JOURNAL OF UROLOGY
- Cost–effectiveness of overactive bladder treatments: from the US payer perspective
- (2018) Brian Murray et al. Journal of Comparative Effectiveness Research
- Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
- (2016) Victor W. Nitti et al. JOURNAL OF UROLOGY
- Patient experience and satisfaction with Onabotulinumtoxin A for refractory overactive bladder
- (2015) Sachin Malde et al. BJU INTERNATIONAL
- OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology
- (2013) David Ginsberg et al. ADVANCES IN THERAPY
- Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?
- (2013) Jai H. Seth et al. BJU INTERNATIONAL
- OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
- (2013) Christopher Chapple et al. EUROPEAN UROLOGY
- OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity
- (2013) Eric Rovner et al. NEUROUROLOGY AND URODYNAMICS
- Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience
- (2012) Adrian Wagg et al. BJU INTERNATIONAL
- Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin Action
- (2012) Ana Coelho et al. EUROPEAN UROLOGY
- OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
- (2012) Victor W. Nitti et al. JOURNAL OF UROLOGY
- Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction
- (2011) Debra E. Irwin et al. BJU INTERNATIONAL
- Repeated Botulinum Toxin Type A Injections for Refractory Overactive Bladder: Medium-Term Outcomes, Safety Profile, and Discontinuation Rates
- (2011) Christopher Dowson et al. EUROPEAN UROLOGY
- Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial
- (2010) Roger Dmochowski et al. JOURNAL OF UROLOGY
- Reviewing the ICS 2002 terminology report: The ongoing debate
- (2009) Paul Abrams et al. NEUROUROLOGY AND URODYNAMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search